/PRNewswire/ Physicians who care for pregnant women have long sought to identify which of their patients would most likely benefit from monitoring of their.
/PRNewswire/ NYU Langone Health is joining a new National Institutes of Health (NIH)-sponsored program called Accelerating Medicines Partnership Autoimmune.
NYU Langone joins NIH-sponsored program called Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases to find new therapies. Learn more.
NYU Langone Health is joining a new National Institutes of Health (NIH)-sponsored program called Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases (AMP AIM) as a leading center to discover new targets for therapy in these diseases.
Nationally recognized for his work studying a novel inflammatory disorder known as VEXAS, David B. Beck, MD, PhD, has joined the Division of Rheumatology at NYU Langone.